BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28057863)

  • 21. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of a human IgA1 Fab fragment at 1.55 Å resolution: potential effect of the constant domains on antigen-affinity modulation.
    Correa A; Trajtenberg F; Obal G; Pritsch O; Dighiero G; Oppezzo P; Buschiazzo A
    Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):388-97. PubMed ID: 23519414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.
    Fellouse FA; Barthelemy PA; Kelley RF; Sidhu SS
    J Mol Biol; 2006 Mar; 357(1):100-14. PubMed ID: 16413576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens.
    Raghunathan G; Smart J; Williams J; Almagro JC
    J Mol Recognit; 2012 Mar; 25(3):103-13. PubMed ID: 22407974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.
    Klarenbeek A; Blanchetot C; Schragel G; Sadi AS; Ongenae N; Hemrika W; Wijdenes J; Spinelli S; Desmyter A; Cambillau C; Hultberg A; Kretz-Rommel A; Dreier T; De Haard HJ; Roovers RC
    Protein Eng Des Sel; 2016 Apr; 29(4):123-33. PubMed ID: 26945588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
    Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
    J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein.
    Tse E; Lobato MN; Forster A; Tanaka T; Chung GT; Rabbitts TH
    J Mol Biol; 2002 Mar; 317(1):85-94. PubMed ID: 11916380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable Domain
    van de Bovenkamp FS; Derksen NIL; van Breemen MJ; de Taeye SW; Ooijevaar-de Heer P; Sanders RW; Rispens T
    Front Immunol; 2018; 9():740. PubMed ID: 29706962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation.
    Wang F; Sen S; Zhang Y; Ahmad I; Zhu X; Wilson IA; Smider VV; Magliery TJ; Schultz PG
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4261-6. PubMed ID: 23440204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the domain pairing in chimeric antibodies.
    Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
    Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
    Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating the binding properties of an anti-17beta-estradiol antibody by systematic mutation combinations.
    Lamminmäki U; Westerlund-Karlsson A; Toivola M; Saviranta P
    Protein Sci; 2003 Nov; 12(11):2549-58. PubMed ID: 14573866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
    Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
    Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
    Evans SV; Rose DR; To R; Young NM; Bundle DR
    J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational changes in antibody Fab fragments upon binding and their consequences on the performance of docking algorithms.
    Barozet A; Bianciotto M; Siméon T; Minoux H; Cortés J
    Immunol Lett; 2018 Aug; 200():5-15. PubMed ID: 29885326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selection and characterization of human antibodies against vascular endothelial growth factor from human phage display antibody library].
    Tian X; Shou C; Dong Z
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):567-70. PubMed ID: 11798817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular recognition by a binary code.
    Fellouse FA; Li B; Compaan DM; Peden AA; Hymowitz SG; Sidhu SS
    J Mol Biol; 2005 May; 348(5):1153-62. PubMed ID: 15854651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.